Evidence map›Paper›PMID 22841832›Full record

ArticleJournal of immunological methods2012

PE-Cy5.5 conjugates bind to the cells expressing mouse DEC205/CD205.

Chae Gyu Park, Anthony Rodriguez, Ralph M Steinman

Abstract read
In one paragraph

Article in Journal of immunological methods, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Bromelain Inhibits Allergic Sensitization and Murine Asthma via Modulation of Dendritic Cells.Evidence-based complementary and alternative medicine : eCAM · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chae Gyu ParkLaboratory of Cellular Physiology and Immunology and Chris Browne Center for Immunology and Immune Diseases, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA. parkc@rockefeller.edu
Anthony Rodriguez
Ralph M Steinman
Rockefeller University · US

Funding

Properties of Mouse of Dendritic Cells and MacrophagesR01AI013013 · NIAID · ROCKEFELLER UNIVERSITY · PI MOJSOV, SVETLANA · 1985 to 2015
$8.9M
Dendritic Cells and the Pathogenesis of HIV-1 InfectionR37AI040045 · NIAID · ROCKEFELLER UNIVERSITY · PI STEINMAN, RALPH MARVIN · 2001 to 2010
$6.1M
Identification and vaccine adjuvant responses of dendritic cells in humansR56AI040045 · NIAID · ROCKEFELLER UNIVERSITY · PI SCHLESINGER, SARAH JANE · 2011 to 2011
$520k
DENDRITIC CELLS AND THE PATHOGENESIS OF HIV-1 INFECTIONR01AI040045 · NIAID · ROCKEFELLER UNIVERSITY · PI STEINMAN, RALPH M. · 1996 to 2000
$457k
New HIV/AIDS vaccines employing inflammatory dendritic cellsR21AI093216 · NIAID · ROCKEFELLER UNIVERSITY · PI PARK, CHAE GYU · 2011 to 2012
$452k
PROPERTIES OF MOUSE DENDRITIC CELLS AND MACROPHAGESR37AI013013 · NIAID · ROCKEFELLER UNIVERSITY · PI STEINMAN, RALPH M. · 1986 to 1995
–
NIAID NIH HHS AI093216NIAID NIH HHS AI13013NIAID NIH HHS AI40045NIAID NIH HHS N01 AI040045NIAID NIH HHS R01 AI013013NIAID NIH HHS R01 AI040045NIAID NIH HHS R21 AI093216
6 · The paper itself

Abstract

DEC205/CD205, an endocytic receptor of C-type multilectin, is expressed highly in dendritic cells (DCs). DEC205 was shown to efficiently deliver vaccine antigens in surrogate ligands to the antigen processing and presentation machinery of DCs, which resulted in the development of DC-targeted vaccines employing anti-DC monoclonal antibodies (mAbs). During our studies to characterize a variety of anti-DC mAbs including anti-DEC205 by flow cytometric analysis, we discovered that a secondary anti-immunoglobulin antibody conjugated with PE-Cy5.5 bound strongly to the cells expressing mouse DEC205 (mDEC205) without incubation of a primary anti-mDEC205 mAb. In the present study we demonstrate that various antibodies and streptavidin conjugated with PE-Cy5.5 bind to the mDEC205-expressing cells including CHO, KIT6, and HEK293 cells. The interaction between the PE-Cy5.5 conjugates and the cells expressing mDEC205 appears distinctive, since none of the PE-Cy5.5 conjugates bind to the cells that express human DEC205 on surface. Besides, only PE-Cy5.5 conjugates bind strongly to mDEC205-expressing cells; PerCP-Cy5.5, APC-Cy5.5, and Cy5.5 conjugates bind weakly; PE, PE-Cy5, Cy5, FITC, or Alexa488 conjugates do not bind to mDEC205-expressing cells. Therefore the use of PE-Cy5.5 conjugates, widely utilized in multicolor flow cytometry, requires precaution against nonspecific binding to mDEC205-positive cells.

Indexed as

AnimalsAntibodies, MonoclonalAntigens, CDBinding, CompetitiveCarbocyaninesCHO CellsCricetinaeCricetulusDendritic CellsFlow CytometryGene ExpressionHEK293 CellsHumansHybridomasImmunoconjugatesLectins, C-TypeAntibodies, MonoclonalAntigens, CDCarbocyaninesCY5.5 cyanine dyeDEC-205 receptorImmunoconjugatesLectins, C-TypeMinor Histocompatibility AntigensReceptors, Cell SurfaceStreptavidin

Identifiers

PMID22841832
PMCPMC3432670
OpenAlexW2031304863

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.